These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24873821)

  • 1. The assessment and characterisation of drug plasma protein binding in the body using QSAR.
    Agatonovic-Kustrin S; Morton DW; Yusof PA
    Mini Rev Med Chem; 2014; 14(6):484-93. PubMed ID: 24873821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro, in silico and integrated strategies for the estimation of plasma protein binding. A review.
    Lambrinidis G; Vallianatou T; Tsantili-Kakoulidou A
    Adv Drug Deliv Rev; 2015 Jun; 86():27-45. PubMed ID: 25819487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do we need to optimize plasma protein and tissue binding in drug discovery?
    Liu X; Chen C; Hop CE
    Curr Top Med Chem; 2011; 11(4):450-66. PubMed ID: 21320069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based druggability assessment--identifying suitable targets for small molecule therapeutics.
    Fauman EB; Rai BK; Huang ES
    Curr Opin Chem Biol; 2011 Aug; 15(4):463-8. PubMed ID: 21704549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Binding of Drug Molecules to Serum Albumin: The Effect of Drug Hydrophobicity on Binding Strength and Protein Desolvation.
    Al-Husseini JK; Stanton NJ; Selassie CRD; Johal MS
    Langmuir; 2019 Dec; 35(52):17054-17060. PubMed ID: 31790590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on binding of drug to serum protein].
    Otagiri M
    Yakugaku Zasshi; 2009 Apr; 129(4):413-25. PubMed ID: 19336995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Silico Prediction of Compounds Binding to Human Plasma Proteins by QSAR Models.
    Sun L; Yang H; Li J; Wang T; Li W; Liu G; Tang Y
    ChemMedChem; 2018 Mar; 13(6):572-581. PubMed ID: 29057587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereoselective binding of chiral drugs to plasma proteins.
    Shen Q; Wang L; Zhou H; Jiang HD; Yu LS; Zeng S
    Acta Pharmacol Sin; 2013 Aug; 34(8):998-1006. PubMed ID: 23852086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement and analysis of unbound drug concentrations.
    Wright JD; Boudinot FD; Ujhelyi MR
    Clin Pharmacokinet; 1996 Jun; 30(6):445-62. PubMed ID: 8792057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative structure--plasma protein binding relationships of acidic drugs.
    Zhivkova Z; Doytchinova I
    J Pharm Sci; 2012 Dec; 101(12):4627-41. PubMed ID: 22961754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug Distribution Part 2. Predicting Volume of Distribution from Plasma Protein Binding and Membrane Partitioning.
    Korzekwa K; Nagar S
    Pharm Res; 2017 Mar; 34(3):544-551. PubMed ID: 27966088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a Novel Quantitative Structure-Activity Relationship Model to Accurately Predict Pulmonary Absorption and Replace Routine Use of the Isolated Perfused Respiring Rat Lung Model.
    Edwards CD; Luscombe C; Eddershaw P; Hessel EM
    Pharm Res; 2016 Nov; 33(11):2604-16. PubMed ID: 27401409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative Structure - Pharmacokinetics Relationships for Plasma Protein Binding of Basic Drugs.
    Zhivkova ZD
    J Pharm Pharm Sci; 2017; 20(1):349-359. PubMed ID: 29145933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Informing the Human Plasma Protein Binding of Environmental Chemicals by Machine Learning in the Pharmaceutical Space: Applicability Domain and Limits of Predictability.
    Ingle BL; Veber BC; Nichols JW; Tornero-Velez R
    J Chem Inf Model; 2016 Nov; 56(11):2243-2252. PubMed ID: 27684444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma/serum protein binding determinations.
    Banker MJ; Clark TH
    Curr Drug Metab; 2008 Nov; 9(9):854-9. PubMed ID: 18991581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of drug interactions with serum proteins by using high-performance affinity chromatography.
    Hage DS; Anguizola J; Barnaby O; Jackson A; Yoo MJ; Papastavros E; Pfaunmiller E; Sobansky M; Tong Z
    Curr Drug Metab; 2011 May; 12(4):313-28. PubMed ID: 21395530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QSAR analysis of blood-brain distribution: the influence of plasma and brain tissue binding.
    Lanevskij K; Dapkunas J; Juska L; Japertas P; Didziapetris R
    J Pharm Sci; 2011 Jun; 100(6):2147-60. PubMed ID: 21271563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentration-dependent plasma protein binding: Expect the unexpected.
    Nation RL; Theuretzbacher U; Tsuji BT;
    Eur J Pharm Sci; 2018 Sep; 122():341-346. PubMed ID: 30026170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting human plasma protein binding of drugs using plasma protein interaction QSAR analysis (PPI-QSAR).
    Li H; Chen Z; Xu X; Sui X; Guo T; Liu W; Zhang J
    Biopharm Drug Dispos; 2011 Sep; 32(6):333-42. PubMed ID: 21800312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug distribution and binding.
    Oie S
    J Clin Pharmacol; 1986; 26(8):583-6. PubMed ID: 3793947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.